{
    "title": "Individual feed for https://www.medscape.com/cx/rssfeeds/2700.xml",
    "link": "https://www.medscape.com/cx/rssfeeds/2700.xml",
    "description": "Individual feed output.",
    "lastBuildDate": "2025-12-10T11:02:06.828691",
    "items": [
        {
            "title": "Semaglutide Tied to 50% Lower Risk for Epilepsy in Diabetes",
            "link": "https://www.medscape.com/viewarticle/semaglutide-tied-50-lower-risk-epilepsy-diabetes-2025a1000ynf?src=rss",
            "description": "The GLP-1 RA, semaglutide, significantly reduces epilepsy risk in diabetes, and this protective signal is driven by pathways unrelated to improvements...",
            "pubDate": "2025-12-10T13:18:38",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture6.png"
        },
        {
            "title": "Carfilzomib Improves Upon Bortezomib for Multiple Myeloma",
            "link": "https://www.medscape.com/viewarticle/carfilzomib-improves-upon-bortezomib-multiple-myeloma-2025a1000yn9?src=rss",
            "description": "In the phase 3 COBRA trial, the carfilzomib/lenalidomide/dexamethasone regimen shows significant improvements in PFS and other outcomes in newly diagn...",
            "pubDate": "2025-12-10T12:41:19",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture4.png"
        },
        {
            "title": "Chemo-Free TKI Plus Immunotherapy Improves PH-Positive ALL",
            "link": "https://www.medscape.com/viewarticle/chemo-free-tki-plus-immunotherapy-improves-ph-positive-all-2025a1000yn5?src=rss",
            "description": "The regimen of ponatinib combined with blinatumomab boosts outcomes vs TKI plus chemotherapy. Medscape Medical News",
            "pubDate": "2025-12-10T12:26:18",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture2.png"
        },
        {
            "title": "UK Medicine Rebate Rate to Drop in 2026 After US Pharma Deal",
            "link": "https://www.medscape.com/s/viewarticle/uk-medicine-rebate-rate-drop-2026-after-us-pharma-deal-2025a1000ynj?src=rss",
            "description": "The British government said on Wednesday that the proportion of revenues from new medicine sales pharmaceutical firms need to pay back into England's ...",
            "pubDate": "2025-12-10T12:03:59",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture7.png"
        },
        {
            "title": "Dual Therapy Shows Promise in Chronic Migraine Prevention",
            "link": "https://www.medscape.com/viewarticle/onabotulinumtoxina-plus-atogepant-shows-promise-chronic-2025a1000yac?src=rss",
            "description": "In patients with chronic migraine, adding atogepant to onabotulinumtoxinA significantly reduces the burden of migraine, achieving a â‰¥ 50% response wit...",
            "pubDate": "2025-12-10T12:00:00",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture10.png"
        }
    ]
}